ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,497.06
      0.26%
      US Tech 100
      19,318.80
      0.28%
      Dow Jones
      39,227.16
      0.16%
      Brent Oil
      85.07
      -0.40%
      Bitcoin
      61,002.84
      -0.99%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Rani Therapeutics Holdings Inc (RANI) Quote

      Rani Therapeutics Holdings Inc

      Rani Therapeutics Holdings Inc (RANI)

      NASDAQ
      3.73
      -0.21
      ( -5.33% )
      Updated: 11:40:38
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      3.73
      Bid
      3.69
      Ask
      3.77
      Volume
      19,549
      3.65 Day's Range 3.96
      1.82 52 Week Range 8.75
      Market Cap
      186.051M
      Previous Close
      3.94
      Open
      3.88
      Last Trade
      200
      @
      3.73
      Last Trade Time
      11:40:38
      Financial Volume
      $ 73,816
      VWAP
      3.776
      Average Volume (3m)
      147,493
      Shares Outstanding
      50,420,315
      Dividend Yield
      -
      PE Ratio
      -5.48
      Earnings Per Share (EPS)
      -0.67
      Revenue
      -
      Net Profit
      -33.97M

      About Rani Therapeutics Holdings Inc

      Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injecti... Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.ranitherapeutics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Rani Therapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RANI. The last closing price for Rani Therapeutics was $3.94. Over the last year, Rani Therapeutics shares have traded in a share price range of $ 1.82 to $ 8.75.

      Rani Therapeutics currently has 50,420,315 shares outstanding. The market capitalization of Rani Therapeutics is $186.05 million. Rani Therapeutics has a price to earnings ratio (PE ratio) of -5.48.

      RANI Latest News

      More News

      Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

      ~ New RT-114 obesity program combines ProGen’s FC Fusion protein conjugated GLP-1/GLP-2 dual agonist, PG-102, with the RaniPill® capsule designed to provide a differentiated oral delivery...

      June 24 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      May 30 2024
      Edgar (US Regulatory)

      Rani Therapeutics to Participate in May Investor Conferences

      SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

      May 14 2024
      GlobeNewswire Inc.

      Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

      SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

      May 09 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 06 2024
      Edgar (US Regulatory)

      Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

      - Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Initiation of Phase 2 clinical trial for RT-102 for the treatment of osteoporosis...

      May 06 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      May 06 2024
      Edgar (US Regulatory)

      Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

      - Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Announced Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1...

      March 20 2024
      GlobeNewswire Inc.

      Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

      SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

      March 15 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      February 05 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.34-8.353808353814.074.373.65633814.00652594CS
      4-1.54-29.22201138525.275.73993.65670634.34679207CS
      120.030.8108108108113.78.753.521474936.15842477CS
      260.4313.03030303033.38.752.821127205.09649173CS
      52-0.39-9.466019417484.128.751.82897744.28076816CS
      156-7.53-66.873889875711.2636.271.828549111.00795617CS
      260-7.53-66.873889875711.2636.271.828549111.00795617CS

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      LUCYInnovative Eyewear Inc
      $ 0.571599
      (73.21%)
      		297.06M
      WHLRWheeler Real Estate Investment Trust Inc
      $ 20.9628
      (58.21%)
      		400.3k
      COSMCosmos Health Inc
      $ 1.00
      (47.28%)
      		69.17M
      NNENano Nuclear Energy Inc
      $ 20.45
      (26.08%)
      		4.52M
      ECDAECD Automotive Design Inc
      $ 1.21
      (25.95%)
      		11.52M
      ACCDAccolade Inc
      $ 3.66
      (-42.72%)
      		6.46M
      CINGCingulate Inc
      $ 0.3596
      (-38.42%)
      		723.18k
      ELTXElicio Therapeutics Inc
      $ 4.26
      (-38.17%)
      		250.29k
      NXLNexalin Technologies Inc
      $ 1.845
      (-37.67%)
      		3.1M
      APVOAptevo Therapeutics Inc
      $ 0.32385
      (-37.10%)
      		1.19M
      LUCYInnovative Eyewear Inc
      $ 0.5716
      (73.21%)
      		297.08M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.5682
      (-5.30%)
      		129.29M
      NVDANVIDIA Corporation
      $ 126.125
      (1.72%)
      		127.26M
      SQQQProShares UltraPro Short QQQ
      $ 8.044
      (-1.06%)
      		76.71M
      COSMCosmos Health Inc
      $ 1.00
      (47.28%)
      		69.17M

      RANI Discussion

      View Posts
      PonkenPlonken PonkenPlonken 1 month ago
      MGRX did 330% today on news of planning to distribute an oral version of GLP1 sometime in the future.
      This company has the platform to produce a promising oral GLP1 option right now.

      You also get some free shots at the goal in 4 other indications.
      👍️0
      Monksdream Monksdream 2 months ago
      RANI under $10
      👍️0
      PonkenPlonken PonkenPlonken 2 months ago
      wants sooo much more
      👍️0
      PonkenPlonken PonkenPlonken 2 months ago
      shake shake the tree
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      RANI...HERE COMES 9.00...LOL
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      RANI...8 DOLLA FLOOR BEING BUILT
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      RANI 8 DOLLA...FORTUNE COOKIE WAS RIGHT....LMAO
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      RANI...LETS SEE 8 BUCKS
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      SOMEONE WITH BRAINS AROUND HERE
      👍️ 1
      TrendTrade2016 TrendTrade2016 2 months ago
      RANI...GAPPING TO 7.50...LMAO...WHAT A CALL FROM THE HOUSE OF TREND
      👍️0
      PonkenPlonken PonkenPlonken 2 months ago
      $RANI can clear worries about GLP adm.
      No sellers in consecutive sessions.
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      ITS RAINING AGAIN WITH RANI...IS TIM ON THIS ONE?!!
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      RANI...LET THEM CHASE THE ALGO FABRICATIONS WHILE WE WATCH RANI TREND TO 7.00
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      RANI...HERE COMES 7.00
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      RANI...BREAKING NEW HIGH
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      RANI...BREAKING 6.00...BIO BEAST!!!
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...ITS RAINING AGAIN
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...HERE WE GO
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI....BIO MONSTER
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...THIN AS THIN...ARCA BID
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...NEXT BIO BEAST READY TO BEAST
      👍️0

      Your Recent History

      NASDAQ
      RANI
      Rani Therapeutics
      Delayed Upgrade Clock